Search

Your search keyword '"Van Poppel H"' showing total 1,806 results

Search Constraints

Start Over You searched for: Author "Van Poppel H" Remove constraint Author: "Van Poppel H"
1,806 results on '"Van Poppel H"'

Search Results

1. Update on the management of invasive bladder cancer 2012

2. Chemoprevention of prostate cancer with nutrients and supplements

3. Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

4. Understanding the barriers to prostate cancer population-based early detection programs: The PRAISE-U BEST survey

5. Natural history of pN1 prostate cancer after radical prostatectomy: Competing risk analysis from a large multi-institutional series

6. Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

7. Correlation between the location of the index tumour and the location of positive lymph nodes in high-risk prostate cancer – a monocentric positive lymph node mapping study

8. Developing and comparing prostate cancer screening specific performance indicators for PRAISE-U

9. Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

10. Why is there a need to re-think prostate cancer early detection?

11. Oncologic outcomes of template vs. radio-guided salvage lymph node dissection for node-only recurrent prostate cancer: Results from a multi-institutional collaboration

13. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

14. Tumoren van de urinewegen

16. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer

17. Radioligand therapies in cancer: mapping the educational landscape in Europe

19. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics

20. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: a novel risk stratification tool

21. Toxicity profile of immediate post-prostatectomy radiation therapy: results from a large multi-institutional series

22. What is the optimal management of nodal oligorecurrent prostate cancer? results from a large series of patients treated with salvage lymph node dissection

23. Oncological outcomes, patterns of recurrence and impact of competing causes of mortality in clinically node-positive prostate cancer patients treated with radical prostatectomy

24. E-book: Screening - Uitgave 2022

27. E-book: Oncologie 2021 - 2022

29. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer

30. Palliative Surgical Therapy

31. Nephron-Sparing Surgery

34. Long-term Results of Brachytherapy with Iridium-192 Implants

35. Complications of Radical Cystectomy

36. Prophylactic Urethrectomy: When and How?

37. Hyperthermia for Carcinoma of the Prostate

38. Surgical Treatment of Carcinoma of the Prostate

39. Complications of Radical Prostatectomy

41. Patterns of Failure in Surgically Treated Patients

42. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics

43. Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy

44. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: A novel risk stratification tool

45. PSA doubling time as predictor of relapse after early salvage radiation therapy: When should imaging be used to select patients who might not benefit from early local treatments?

47. Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?

49. Introducing PIONEER: a project to harness big data in prostate cancer research

50. Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x)

Catalog

Books, media, physical & digital resources